Literature DB >> 19028354

Human genetics of osteoporosis.

Serge Ferrari1.   

Abstract

A family history of hip fracture carries a twofold increased risk of fracture among descendants. Genetic factors indeed play a major role in the determination of bone mineral density (BMD) and osteoporosis risk. Multiple chromosomal loci have been mapped by linkage approaches which potentially carry hundreds of genes involved in the determination of bone mass and quality. Association studies based on candidate gene polymorphisms and subsequent meta-analyses, and the more recent genome-wide association studies (GWAS), have clearly identified a handful of genes associated with BMD and/or fragility fractures. Among them are genes coding for the LDL-receptor related protein 5 (LRP5), estrogen receptor alpha (ESR1) and osteoprotegerin, OPG (TNFRSf11b). However, the percentage of osteoporosis risk explained by any of these polymorphisms is small, indicating that most genetic risk factors remain to be discovered and/or that interaction with environmental factors needs further consideration.

Entities:  

Mesh:

Year:  2008        PMID: 19028354     DOI: 10.1016/j.beem.2008.08.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  40 in total

1.  Congenic mice provide in vivo evidence for a genetic locus that modulates intrinsic transforming growth factor β1-mediated signaling and bone acquisition.

Authors:  Aditi Mukherjee; Emily A Larson; Amy S Carlos; John K Belknap; Peter Rotwein; Robert F Klein
Journal:  J Bone Miner Res       Date:  2012-06       Impact factor: 6.741

2.  Polymorphisms in Wnt signaling pathway genes are associated with peak bone mineral density, lean mass, and fat mass in Chinese male nuclear families.

Authors:  Y Zheng; C Wang; H Zhang; C Shao; L-H Gao; S-S Li; W-J Yu; J-W He; W-Z Fu; Y-Q Hu; M Li; Y-J Liu; Z-L Zhang
Journal:  Osteoporos Int       Date:  2016-01-05       Impact factor: 4.507

3.  Genetic susceptibility of postmenopausal osteoporosis on sulfide quinone reductase-like gene.

Authors:  X Cai; X Yi; Y Zhang; D Zhang; L Zhi; H Liu
Journal:  Osteoporos Int       Date:  2018-05-31       Impact factor: 4.507

4.  Polymorphisms in the macrophage migration inhibitory factor gene and bone loss in postmenopausal women.

Authors:  Maria Swanberg; Fiona McGuigan; Kaisa K Ivaska; Paul Gerdhem; Ulf H Lerner; Richard Bucala; George Kuchel; Anne Kenny; Kristina Akesson
Journal:  Bone       Date:  2010-05-12       Impact factor: 4.398

Review 5.  Sclerosing bone dysplasias: leads toward novel osteoporosis treatments.

Authors:  Igor Fijalkowski; Eveline Boudin; Geert Mortier; Wim Van Hul
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

Review 6.  Unveiling the mysteries of the genetics of osteoporosis.

Authors:  N Alonso; S H Ralston
Journal:  J Endocrinol Invest       Date:  2014-08-23       Impact factor: 4.256

7.  Association of Vitamin D Receptor (FokI and BsmI) Gene Polymorphism with Bone Mineral Density and Their Effect on 25-Hydroxyvitamin D Level in North Indian Postmenopausal Women with Osteoporosis.

Authors:  Israr Ahmad; Tabrez Jafar; Farzana Mahdi; Md Arshad; Siddharth Kumar Das; Shah Waliullah; Abbas Ali Mahdi
Journal:  Indian J Clin Biochem       Date:  2017-10-28

8.  Genetic association study of WNT10B polymorphisms with BMD and adiposity parameters in Danish and Belgian males.

Authors:  Jasmijn K Van Camp; Sigri Beckers; Doreen Zegers; Eveline Boudin; Torben Leo Nielsen; Marianne Andersen; Greet Roef; Youri Taes; Kim Brixen; Wim Van Hul
Journal:  Endocrine       Date:  2013-01-17       Impact factor: 3.633

9.  Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women.

Authors:  Feng Zhang; Chunlei He; Gang Chen; Fangcai Li; Hui Gao
Journal:  Med Oncol       Date:  2013-01-19       Impact factor: 3.064

10.  How genomics has informed our understanding of the pathogenesis of osteoporosis.

Authors:  Mark L Johnson; Nuria Lara; Mohamed A Kamel
Journal:  Genome Med       Date:  2009-09-07       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.